Osaühing FibroTx
- Registry code
- 11183541
- VAT number
- EE101015402
- Address
- Harju maakond, Tallinn, Mustamäe linnaosa, Mäealuse tn 4/1, 12618
- Registered
- 07.11.2005 · 20 yrs
- Activity
- Research and experimental development on biotechnology 72111
- Capital
- 80 000 €
- a•••@m•••.eeLog in to see
- Phone
- +372 •• ••••Log in to see
Business Register 05.10.2026
Likvideerimisel
Likvideerimisel või registrist kustutatud: tegevus puudub
Negatiivne omakapital, madal likviidsus ja raha alla kuu kulude
Tegevuseta: käive ja töötajad puuduvad
Käive, 4 kvartalit0 €EMTA, viimased 4 kvartalit
Profit-233 k €2024 annual report
Cash2 €Cash 24.04.2025, annual report
Tax debt0 €Tax Board debtor list 05.10.2026
Quick check
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- Bankruptcy or liquidation
- No sanctions
- Report filed (2024)
- VAT registered
Stability
Follow companyNotification when something changesRatingC since 26.09.2026
In tax debt0 days since 26.09.2026
Board and owners
2 persons
| Other persons 2 | ||
|---|---|---|
| Aivar Linnamäe7 companiesno tax debtLiquidator | Personal ID ↗ | 15.05.2023 |
| Nasdaq CSD SEOsade registripidajaOsad on Eesti väärtpaberite registris (Nasdaq CSD). See ei tähenda börsil noteerimist. | 28.09.2017 | |
| Shareholders 6 | ||
| Omanikukonto: MM HOLDINGS B.V. | 24,75% 19 800 € | 16.08.2023 |
| Omanikukonto: AKH INVESTEERINGUD OÜ | 24,0% 19 200 € | 05.12.2025 |
| Omanikukonto: OÜ PROTOBIOS | 18,0% 14 400 € | 16.08.2023 |
| Omanikukonto: AIFAL OÜ | 17,49% 13 991 € | 05.12.2025 |
| Omanikukonto: KÄHRI & KAARIN OÜ | 12,76% 10 209 € | 16.08.2023 |
| Omanikukonto: OÜ LOST GORILLAS | 3,0% 2 400 € | 16.08.2023 |
| Beneficial owners 1 | ||
| Aivar Linnamäe7 companiesno tax debtkaudne osalus | 01.09.2020 | |
Business Register open data
Quarterly taxes and revenue
2026 Q2
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2026 Q2 | 0 € | — | — | — | |
| 2026 Q1 | 0 € | — | — | — | |
| 2025 Q4 | 0 € | — | — | — | |
| 2025 Q3 | 0 € | — | — | — | |
| 2025 Q2 | 0 € | — | — | — | |
| 2025 Q1 | 0 € | — | — | — | |
| 2024 Q4 | 0 € | — | — | — | |
| 2024 Q3 | 0 € | — | — | — | |
| 2024 Q2 | 0 € | — | — | — | |
| 2024 Q1 | 0 € | — | — | — | |
| 2023 Q4 | 0 € | 32 € | 0 € | — | |
| 2023 Q3 | 0 € | 0 € | 0 € | — |
Show full history (18 quarters)
| 2023 Q2 | 0 € | 0 € | 0 € | — | |
| 2023 Q1 | 2 760 € | ▼ 98% | 31 723 € | 17 627 € | — |
| 2022 Q4 | 27 718 € | 51 619 € | 0 € | 9 | |
| 2022 Q3 | 57 273 € | 28 279 € | 0 € | 16 | |
| 2022 Q2 | 26 752 € | 35 851 € | 0 € | 17 | |
| 2022 Q1 | 118 364 € | 34 129 € | 12 549 € | 20 |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
4 yr
| 2024 | 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|---|
| Sales revenue | — | — | — | 222 k € | |||
| Profit | -233 k € | ▲ 71% | -799 k € | — | -1,6 m € | ||
| Profit margin | — | — | — | -709,1% | |||
| Retained earnings | -16,2 m € | ▼ 5% | -15,4 m € | — | -8,8 m € | ||
| Cash | 2 € | ▼ 71% | 7 € | — | 19 878 € | ||
| Current assets | 2 € | ▼ 71% | 7 € | — | 166 k € | ||
| Fixed assets | — | — | — | 2,1 m € | |||
| Assets | 2 € | ▼ 71% | 7 € | — | 2,2 m € | ||
| Current liabilities | 11,3 m € | ▲ 2% | 11,1 m € | — | 1,2 m € | ||
| Long-term liabilities | — | — | — | 6,4 m € | |||
| Total liabilities | 11,3 m € | ▲ 2% | 11,1 m € | — | 7,5 m € | ||
| Equity | -11,3 m € | ▼ 2% | -11,1 m € | — | -5,3 m € | ||
| Labour costs | — | — | 379 k € | ▲ into profit | -449 k € | ||
| Employees | — | — | 7 | ▼ 22% | 9 | ||
| Filed | 15.10.2025 | 13.08.2024 | 27.06.2023 | 07.07.2022 | |||
| Report | PDF ↓ | PDF ↓ | PDF ↓ | PDF ↓ |
▲ growth, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2021
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Research and experimental development on biotechnology main activity | 72111 | 221 916 € | 100% |
2021 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
No tax debt · Tax Board 05.10.2026
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
avalikke teateid pole
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
8 toetust
Toetuse saanud projektid
| Projekt | Meede | Periood | Toetus | Välja makstud |
|---|---|---|---|---|
| Development of transdermal analysis patch for cosmetic and dermatology use Lõpetatud · Ettevõtluse ja Innovatsiooni Sihtasutus | Teadus- ja arendustegevuse projektide toetamine | 01.07.2011 – 30.06.2014 | 3 968 538 € | |
| Hübridoomide arendamine personaalkosmeetika produkti loomiseks Lõpetatud · Ettevõtluse ja Innovatsiooni Sihtasutus | Innovatsiooniosakute toetusmeede | 13.03.2009 – 12.03.2010 | 2 652 € | |
| Haavade paranemise stimuleerimine: personaalmeditsiiniline lähenemine Lõpetatud · Ettevõtluse ja Innovatsiooni Sihtasutus | Teadus- ja arendustegevuse projektide toetamine | 15.10.2008 – 15.10.2011 | 2 218 779 € | |
| Kvaliteedijuhtimissüsteemi arendus Lõpetatud · Ettevõtluse ja Innovatsiooni Sihtasutus | Ettevõtete arengu toetamine | 01.04.2008 – 31.08.2008 | 4 506 € | |
| Naha haavade hüpertroofse armkoe tekke vältimine Lõpetatud · Ettevõtluse ja Innovatsiooni Sihtasutus | Teadus- ja arendustegevuse, innovatsiooni edendamine | 15.02.2008 – 31.03.2008 | 9 797 € | |
| Personaalse nahahoolduse testide väljatöötamine. Lõpetatud · Ettevõtluse ja Innovatsiooni Sihtasutus | Teadus- ja arendustegevuse, innovatsiooni edendamine | 10.12.2007 – 07.02.2008 | 15 750 € | |
| Rakkude vaheaine sünteesi moduleerimine: uus lähenemine kosmeetilistele problee Lõpetatud · Ettevõtluse ja Innovatsiooni Sihtasutus | Teadus- ja arendustegevuse, innovatsiooni edendamine | 01.06.2006 – 30.06.2008 | 533 864 € | |
| Teadus- ja arendustegevuse projekti koostamine Lõpetatud · Ettevõtluse ja Innovatsiooni Sihtasutus | Ettevõtete arengu toetamine | 09.02.2006 – 05.05.2006 | 3 963 € |
Riigi Tugiteenuste Keskus, toetatud projektid
Holdings in other companies
0
No holdings in other companies
Companies linked via the board
6
Top 20 in activity: Research and experimental development on biotechnology
4
| # | Company | Revenue |
|---|---|---|
| 1 | GeneCode AS | 1,1 m € |
| 2 | SMOBYA OÜ | 8 413 € |
| 3 | Tiit Vaasna | 1 514 € |
| 4 | Follistic OÜ | 152 € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Licences, pledges, domains
No data
History and notices
20
| Date | Type | Content |
|---|---|---|
| 15.05.2023 | Entry | Lõpetamiskanne |
| 03.05.2023 | Order to remedy deficiencies | Lõpetamiskanne |
| 27.12.2019 | Entry | Amendment entry |
| 05.04.2019 | Entry | Amendment entry |
| 17.01.2018 | Entry | Amendment entry |
| 29.11.2017 | Entry | Amendment entry |
| 28.09.2017 | Entry | Amendment entry |
| 11.06.2015 | Entry | Amendment entry |
| 15.04.2013 | Entry | Amendment entry |
| 26.02.2013 | Entry | Amendment entry |
| 07.11.2012 | Negative entry order: deficiencies not remedied | Amendment entry |
| 03.10.2012 | Order to remedy deficiencies | Amendment entry |
| 09.03.2012 | Entry | Amendment entry |
| 30.12.2011 | Entry | Amendment entry |
| 09.12.2011 | Order to remedy deficiencies | Amendment entry |
| 21.09.2011 | Entry | Amendment entry |
| 05.01.2009 | Tegevusalade kustutamine registrikaardilt | Amendment entry |
| 26.05.2008 | Entry | Amendment entry |
| 04.05.2006 | Entry | Amendment entry |
| 07.11.2005 | Jaatav kandeotsus | First entry |